SEATTLE, Wash., April 14, 2020 — CuraCloud Corporation announced April 13, 2020, that its computer aided triage and notification system for early recognition of intracranial hemorrhage (ICH) from head CT scans has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). CuraRad-ICH is a software workflow tool designed to aid in prioritizing the clinical assessment of adult non-contrast head CT cases with features suggestive of acute ICH. CuraRad-ICH analyzes cases using deep learning algorithms to identify suspected ICH findings. It makes case-level output available to a PACS/workstation for worklist prioritization or triage purposes.
About CuraCloud Corporation
This resource was first published prior to the 2020 rebranding of CuraCloud to Keya Medical. The content reflects our legacy brand.